AAV-mediated knockdown of Peripherin-2 in vivo using miRNA-based hairpins

Gene therapy for inherited retinal degeneration in which expression of a mutant allele has a gain-of-function effect on photoreceptor cells is likely to depend on efficient silencing of the mutated allele. Peripherin-2 ( Prph2 , also known as peripherin/RDS) is an abundantly expressed photoreceptor-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gene therapy 2010-04, Vol.17 (4), p.486-493
Hauptverfasser: Georgiadis, A, Tschernutter, M, Bainbridge, J W B, Robbie, S J, McIntosh, J, Nathwani, A C, Smith, A J, Ali, R R
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 493
container_issue 4
container_start_page 486
container_title Gene therapy
container_volume 17
creator Georgiadis, A
Tschernutter, M
Bainbridge, J W B
Robbie, S J
McIntosh, J
Nathwani, A C
Smith, A J
Ali, R R
description Gene therapy for inherited retinal degeneration in which expression of a mutant allele has a gain-of-function effect on photoreceptor cells is likely to depend on efficient silencing of the mutated allele. Peripherin-2 ( Prph2 , also known as peripherin/RDS) is an abundantly expressed photoreceptor-specific gene. In humans, gain-of-function mutations in PRPH2 result in both autosomal dominant retinitis pigmentosa and dominant maculopathies. Gene-silencing strategies for these conditions include RNA interference by short hairpin RNAs (shRNAs). Recent evidence suggests that microRNA (miRNA)-based hairpins may offer a safer and more effective alternative. In this study, we used for the first time a virally transferred miRNA-based hairpin to silence Prph2 in the murine retina. The results show that an miRNA-based shRNA can efficiently and specifically silence Prph2 in vivo as early as 3 weeks after AAV2/8-mediated subretinal delivery, leading to a nearly 50% reduction of photoreceptor cells after 5 weeks. We conclude that miRNA-based hairpins can achieve rapid and robust gene silencing after efficient vector-mediated delivery to the retina. The rationale of using an miRNA-based template to improve the silencing efficiency of a hairpin may prove valuable for allele-specific silencing in which the choice for an RNAi target is limited and offers an alternative therapeutic strategy for the treatment of dominant retinopathies.
doi_str_mv 10.1038/gt.2009.162
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_746306935</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A224168240</galeid><sourcerecordid>A224168240</sourcerecordid><originalsourceid>FETCH-LOGICAL-c611t-97e8e736a980f705c53133f36cde91589601cef59e38693b33dc3a7042e0423b3</originalsourceid><addsrcrecordid>eNqF0tuL1DAUB-AiijuuPvkuRXFFtGNuTZrHsngZWFTWy2vIpGknu20yJu2u_veeYUbHkRUJTWj7nRwSfln2EKM5RrR61Y1zgpCcY05uZTPMBC9KxsntbIYkl4XApDrK7qV0gRBioiJ3syPwGHHCZ9mirr8Wg22cHm2TX_pgLptw7fPQ5h9tdOsVTL4gufP5lbsK-ZSc7_LBnb-vi6VOULPSLq6dT_ezO63uk32wW4-zL29efz59V5x9eLs4rc8KwzEeCylsZQXlWlaoFag0JcWUtpSbxkpcVpIjbGxbSksrLumS0sZQLRAjFh54P86ebfddx_BtsmlUg0vG9r32NkxJCcYpgsry_5JCixIRDvLJX_IiTNHDMRThjHFWIilBPf6nwpXAjFdiv1Wne6ucb8MYtdk0VjUhDPOKMARqfoOC0djBmeBt6-D7QcHzgwIwo_0-dnpKSS0-nR_akz_syup-XKXQT6MLPh3CF1toYkgp2latoxt0_KEwUptsqW5Um2wpyBboR7vjT0tIzG_7K0wAnu6ATkb3bdTeuLR3pOQYLhLcy61L8Mt3Nu7v8aa-PwE5wNzN</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>218714687</pqid></control><display><type>article</type><title>AAV-mediated knockdown of Peripherin-2 in vivo using miRNA-based hairpins</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Georgiadis, A ; Tschernutter, M ; Bainbridge, J W B ; Robbie, S J ; McIntosh, J ; Nathwani, A C ; Smith, A J ; Ali, R R</creator><creatorcontrib>Georgiadis, A ; Tschernutter, M ; Bainbridge, J W B ; Robbie, S J ; McIntosh, J ; Nathwani, A C ; Smith, A J ; Ali, R R</creatorcontrib><description>Gene therapy for inherited retinal degeneration in which expression of a mutant allele has a gain-of-function effect on photoreceptor cells is likely to depend on efficient silencing of the mutated allele. Peripherin-2 ( Prph2 , also known as peripherin/RDS) is an abundantly expressed photoreceptor-specific gene. In humans, gain-of-function mutations in PRPH2 result in both autosomal dominant retinitis pigmentosa and dominant maculopathies. Gene-silencing strategies for these conditions include RNA interference by short hairpin RNAs (shRNAs). Recent evidence suggests that microRNA (miRNA)-based hairpins may offer a safer and more effective alternative. In this study, we used for the first time a virally transferred miRNA-based hairpin to silence Prph2 in the murine retina. The results show that an miRNA-based shRNA can efficiently and specifically silence Prph2 in vivo as early as 3 weeks after AAV2/8-mediated subretinal delivery, leading to a nearly 50% reduction of photoreceptor cells after 5 weeks. We conclude that miRNA-based hairpins can achieve rapid and robust gene silencing after efficient vector-mediated delivery to the retina. The rationale of using an miRNA-based template to improve the silencing efficiency of a hairpin may prove valuable for allele-specific silencing in which the choice for an RNAi target is limited and offers an alternative therapeutic strategy for the treatment of dominant retinopathies.</description><identifier>ISSN: 0969-7128</identifier><identifier>EISSN: 1476-5462</identifier><identifier>DOI: 10.1038/gt.2009.162</identifier><identifier>PMID: 20010626</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>Alleles ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Animals ; Applied cell therapy and gene therapy ; Base Pairing ; Base Sequence ; Biological and medical sciences ; Biomedical and Life Sciences ; Biomedicine ; Biotechnology ; Blotting, Western ; Care and treatment ; Cell Biology ; Cellular biology ; Dependovirus ; Dependoviruses ; Development and progression ; DNA Primers - genetics ; Fundamental and applied biological sciences. Psychology ; Gene Expression ; Gene silencing ; Gene Therapy ; Genetic aspects ; Genetic Therapy - methods ; Health aspects ; Health. Pharmaceutical industry ; Human Genetics ; Immunohistochemistry ; Industrial applications and implications. Economical aspects ; Intermediate Filament Proteins - genetics ; Medical sciences ; Membrane Glycoproteins - genetics ; Methods ; Mice ; MicroRNAs ; MicroRNAs - genetics ; miRNA ; Molecular Sequence Data ; Mutation ; Nanotechnology ; Nerve Tissue Proteins - genetics ; original-article ; Peripherin ; Peripherins ; Photoreceptors ; Physiological aspects ; Properties ; Retina ; Retinal degeneration ; Retinal Degeneration - genetics ; Retinal Degeneration - therapy ; Retinal diseases ; Retinitis ; Retinitis pigmentosa ; Reverse Transcriptase Polymerase Chain Reaction ; Ribonucleic acid ; RNA ; RNA Interference ; RNA-mediated interference ; Synthesis ; Transfusions. Complications. Transfusion reactions. Cell and gene therapy</subject><ispartof>Gene therapy, 2010-04, Vol.17 (4), p.486-493</ispartof><rights>Macmillan Publishers Limited 2010</rights><rights>2015 INIST-CNRS</rights><rights>COPYRIGHT 2010 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group Apr 2010</rights><rights>Macmillan Publishers Limited 2010.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c611t-97e8e736a980f705c53133f36cde91589601cef59e38693b33dc3a7042e0423b3</citedby><cites>FETCH-LOGICAL-c611t-97e8e736a980f705c53133f36cde91589601cef59e38693b33dc3a7042e0423b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,782,786,27931,27932</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=22561509$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20010626$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Georgiadis, A</creatorcontrib><creatorcontrib>Tschernutter, M</creatorcontrib><creatorcontrib>Bainbridge, J W B</creatorcontrib><creatorcontrib>Robbie, S J</creatorcontrib><creatorcontrib>McIntosh, J</creatorcontrib><creatorcontrib>Nathwani, A C</creatorcontrib><creatorcontrib>Smith, A J</creatorcontrib><creatorcontrib>Ali, R R</creatorcontrib><title>AAV-mediated knockdown of Peripherin-2 in vivo using miRNA-based hairpins</title><title>Gene therapy</title><addtitle>Gene Ther</addtitle><addtitle>Gene Ther</addtitle><description>Gene therapy for inherited retinal degeneration in which expression of a mutant allele has a gain-of-function effect on photoreceptor cells is likely to depend on efficient silencing of the mutated allele. Peripherin-2 ( Prph2 , also known as peripherin/RDS) is an abundantly expressed photoreceptor-specific gene. In humans, gain-of-function mutations in PRPH2 result in both autosomal dominant retinitis pigmentosa and dominant maculopathies. Gene-silencing strategies for these conditions include RNA interference by short hairpin RNAs (shRNAs). Recent evidence suggests that microRNA (miRNA)-based hairpins may offer a safer and more effective alternative. In this study, we used for the first time a virally transferred miRNA-based hairpin to silence Prph2 in the murine retina. The results show that an miRNA-based shRNA can efficiently and specifically silence Prph2 in vivo as early as 3 weeks after AAV2/8-mediated subretinal delivery, leading to a nearly 50% reduction of photoreceptor cells after 5 weeks. We conclude that miRNA-based hairpins can achieve rapid and robust gene silencing after efficient vector-mediated delivery to the retina. The rationale of using an miRNA-based template to improve the silencing efficiency of a hairpin may prove valuable for allele-specific silencing in which the choice for an RNAi target is limited and offers an alternative therapeutic strategy for the treatment of dominant retinopathies.</description><subject>Alleles</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Animals</subject><subject>Applied cell therapy and gene therapy</subject><subject>Base Pairing</subject><subject>Base Sequence</subject><subject>Biological and medical sciences</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Biotechnology</subject><subject>Blotting, Western</subject><subject>Care and treatment</subject><subject>Cell Biology</subject><subject>Cellular biology</subject><subject>Dependovirus</subject><subject>Dependoviruses</subject><subject>Development and progression</subject><subject>DNA Primers - genetics</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gene Expression</subject><subject>Gene silencing</subject><subject>Gene Therapy</subject><subject>Genetic aspects</subject><subject>Genetic Therapy - methods</subject><subject>Health aspects</subject><subject>Health. Pharmaceutical industry</subject><subject>Human Genetics</subject><subject>Immunohistochemistry</subject><subject>Industrial applications and implications. Economical aspects</subject><subject>Intermediate Filament Proteins - genetics</subject><subject>Medical sciences</subject><subject>Membrane Glycoproteins - genetics</subject><subject>Methods</subject><subject>Mice</subject><subject>MicroRNAs</subject><subject>MicroRNAs - genetics</subject><subject>miRNA</subject><subject>Molecular Sequence Data</subject><subject>Mutation</subject><subject>Nanotechnology</subject><subject>Nerve Tissue Proteins - genetics</subject><subject>original-article</subject><subject>Peripherin</subject><subject>Peripherins</subject><subject>Photoreceptors</subject><subject>Physiological aspects</subject><subject>Properties</subject><subject>Retina</subject><subject>Retinal degeneration</subject><subject>Retinal Degeneration - genetics</subject><subject>Retinal Degeneration - therapy</subject><subject>Retinal diseases</subject><subject>Retinitis</subject><subject>Retinitis pigmentosa</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>Ribonucleic acid</subject><subject>RNA</subject><subject>RNA Interference</subject><subject>RNA-mediated interference</subject><subject>Synthesis</subject><subject>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</subject><issn>0969-7128</issn><issn>1476-5462</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqF0tuL1DAUB-AiijuuPvkuRXFFtGNuTZrHsngZWFTWy2vIpGknu20yJu2u_veeYUbHkRUJTWj7nRwSfln2EKM5RrR61Y1zgpCcY05uZTPMBC9KxsntbIYkl4XApDrK7qV0gRBioiJ3syPwGHHCZ9mirr8Wg22cHm2TX_pgLptw7fPQ5h9tdOsVTL4gufP5lbsK-ZSc7_LBnb-vi6VOULPSLq6dT_ezO63uk32wW4-zL29efz59V5x9eLs4rc8KwzEeCylsZQXlWlaoFag0JcWUtpSbxkpcVpIjbGxbSksrLumS0sZQLRAjFh54P86ebfddx_BtsmlUg0vG9r32NkxJCcYpgsry_5JCixIRDvLJX_IiTNHDMRThjHFWIilBPf6nwpXAjFdiv1Wne6ucb8MYtdk0VjUhDPOKMARqfoOC0djBmeBt6-D7QcHzgwIwo_0-dnpKSS0-nR_akz_syup-XKXQT6MLPh3CF1toYkgp2latoxt0_KEwUptsqW5Um2wpyBboR7vjT0tIzG_7K0wAnu6ATkb3bdTeuLR3pOQYLhLcy61L8Mt3Nu7v8aa-PwE5wNzN</recordid><startdate>20100401</startdate><enddate>20100401</enddate><creator>Georgiadis, A</creator><creator>Tschernutter, M</creator><creator>Bainbridge, J W B</creator><creator>Robbie, S J</creator><creator>McIntosh, J</creator><creator>Nathwani, A C</creator><creator>Smith, A J</creator><creator>Ali, R R</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ISR</scope><scope>3V.</scope><scope>7QP</scope><scope>7TK</scope><scope>7TM</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>RC3</scope><scope>7X8</scope><scope>7QO</scope></search><sort><creationdate>20100401</creationdate><title>AAV-mediated knockdown of Peripherin-2 in vivo using miRNA-based hairpins</title><author>Georgiadis, A ; Tschernutter, M ; Bainbridge, J W B ; Robbie, S J ; McIntosh, J ; Nathwani, A C ; Smith, A J ; Ali, R R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c611t-97e8e736a980f705c53133f36cde91589601cef59e38693b33dc3a7042e0423b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Alleles</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Animals</topic><topic>Applied cell therapy and gene therapy</topic><topic>Base Pairing</topic><topic>Base Sequence</topic><topic>Biological and medical sciences</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Biotechnology</topic><topic>Blotting, Western</topic><topic>Care and treatment</topic><topic>Cell Biology</topic><topic>Cellular biology</topic><topic>Dependovirus</topic><topic>Dependoviruses</topic><topic>Development and progression</topic><topic>DNA Primers - genetics</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gene Expression</topic><topic>Gene silencing</topic><topic>Gene Therapy</topic><topic>Genetic aspects</topic><topic>Genetic Therapy - methods</topic><topic>Health aspects</topic><topic>Health. Pharmaceutical industry</topic><topic>Human Genetics</topic><topic>Immunohistochemistry</topic><topic>Industrial applications and implications. Economical aspects</topic><topic>Intermediate Filament Proteins - genetics</topic><topic>Medical sciences</topic><topic>Membrane Glycoproteins - genetics</topic><topic>Methods</topic><topic>Mice</topic><topic>MicroRNAs</topic><topic>MicroRNAs - genetics</topic><topic>miRNA</topic><topic>Molecular Sequence Data</topic><topic>Mutation</topic><topic>Nanotechnology</topic><topic>Nerve Tissue Proteins - genetics</topic><topic>original-article</topic><topic>Peripherin</topic><topic>Peripherins</topic><topic>Photoreceptors</topic><topic>Physiological aspects</topic><topic>Properties</topic><topic>Retina</topic><topic>Retinal degeneration</topic><topic>Retinal Degeneration - genetics</topic><topic>Retinal Degeneration - therapy</topic><topic>Retinal diseases</topic><topic>Retinitis</topic><topic>Retinitis pigmentosa</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>Ribonucleic acid</topic><topic>RNA</topic><topic>RNA Interference</topic><topic>RNA-mediated interference</topic><topic>Synthesis</topic><topic>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Georgiadis, A</creatorcontrib><creatorcontrib>Tschernutter, M</creatorcontrib><creatorcontrib>Bainbridge, J W B</creatorcontrib><creatorcontrib>Robbie, S J</creatorcontrib><creatorcontrib>McIntosh, J</creatorcontrib><creatorcontrib>Nathwani, A C</creatorcontrib><creatorcontrib>Smith, A J</creatorcontrib><creatorcontrib>Ali, R R</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><jtitle>Gene therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Georgiadis, A</au><au>Tschernutter, M</au><au>Bainbridge, J W B</au><au>Robbie, S J</au><au>McIntosh, J</au><au>Nathwani, A C</au><au>Smith, A J</au><au>Ali, R R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>AAV-mediated knockdown of Peripherin-2 in vivo using miRNA-based hairpins</atitle><jtitle>Gene therapy</jtitle><stitle>Gene Ther</stitle><addtitle>Gene Ther</addtitle><date>2010-04-01</date><risdate>2010</risdate><volume>17</volume><issue>4</issue><spage>486</spage><epage>493</epage><pages>486-493</pages><issn>0969-7128</issn><eissn>1476-5462</eissn><abstract>Gene therapy for inherited retinal degeneration in which expression of a mutant allele has a gain-of-function effect on photoreceptor cells is likely to depend on efficient silencing of the mutated allele. Peripherin-2 ( Prph2 , also known as peripherin/RDS) is an abundantly expressed photoreceptor-specific gene. In humans, gain-of-function mutations in PRPH2 result in both autosomal dominant retinitis pigmentosa and dominant maculopathies. Gene-silencing strategies for these conditions include RNA interference by short hairpin RNAs (shRNAs). Recent evidence suggests that microRNA (miRNA)-based hairpins may offer a safer and more effective alternative. In this study, we used for the first time a virally transferred miRNA-based hairpin to silence Prph2 in the murine retina. The results show that an miRNA-based shRNA can efficiently and specifically silence Prph2 in vivo as early as 3 weeks after AAV2/8-mediated subretinal delivery, leading to a nearly 50% reduction of photoreceptor cells after 5 weeks. We conclude that miRNA-based hairpins can achieve rapid and robust gene silencing after efficient vector-mediated delivery to the retina. The rationale of using an miRNA-based template to improve the silencing efficiency of a hairpin may prove valuable for allele-specific silencing in which the choice for an RNAi target is limited and offers an alternative therapeutic strategy for the treatment of dominant retinopathies.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>20010626</pmid><doi>10.1038/gt.2009.162</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0969-7128
ispartof Gene therapy, 2010-04, Vol.17 (4), p.486-493
issn 0969-7128
1476-5462
language eng
recordid cdi_proquest_miscellaneous_746306935
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Alleles
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Animals
Applied cell therapy and gene therapy
Base Pairing
Base Sequence
Biological and medical sciences
Biomedical and Life Sciences
Biomedicine
Biotechnology
Blotting, Western
Care and treatment
Cell Biology
Cellular biology
Dependovirus
Dependoviruses
Development and progression
DNA Primers - genetics
Fundamental and applied biological sciences. Psychology
Gene Expression
Gene silencing
Gene Therapy
Genetic aspects
Genetic Therapy - methods
Health aspects
Health. Pharmaceutical industry
Human Genetics
Immunohistochemistry
Industrial applications and implications. Economical aspects
Intermediate Filament Proteins - genetics
Medical sciences
Membrane Glycoproteins - genetics
Methods
Mice
MicroRNAs
MicroRNAs - genetics
miRNA
Molecular Sequence Data
Mutation
Nanotechnology
Nerve Tissue Proteins - genetics
original-article
Peripherin
Peripherins
Photoreceptors
Physiological aspects
Properties
Retina
Retinal degeneration
Retinal Degeneration - genetics
Retinal Degeneration - therapy
Retinal diseases
Retinitis
Retinitis pigmentosa
Reverse Transcriptase Polymerase Chain Reaction
Ribonucleic acid
RNA
RNA Interference
RNA-mediated interference
Synthesis
Transfusions. Complications. Transfusion reactions. Cell and gene therapy
title AAV-mediated knockdown of Peripherin-2 in vivo using miRNA-based hairpins
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T08%3A41%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=AAV-mediated%20knockdown%20of%20Peripherin-2%20in%20vivo%20using%20miRNA-based%20hairpins&rft.jtitle=Gene%20therapy&rft.au=Georgiadis,%20A&rft.date=2010-04-01&rft.volume=17&rft.issue=4&rft.spage=486&rft.epage=493&rft.pages=486-493&rft.issn=0969-7128&rft.eissn=1476-5462&rft_id=info:doi/10.1038/gt.2009.162&rft_dat=%3Cgale_proqu%3EA224168240%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=218714687&rft_id=info:pmid/20010626&rft_galeid=A224168240&rfr_iscdi=true